Lottery.com, WinTogether.org Kick Off Clean Oceans Campaign, Mark First-Time Partnerships
July 16, 2021
Clean Oceans campaign set to drive one of the largest ocean plastics cleanups in history. Campaign offers participants weekly prizes and one $50,000 grand prize. Powered by Lottery.com, WinTogether.org innovates the way charitable organizations raise funds and interact with donors. WinTogether.org, a charitable sweepstakes platform powered by Lottery.com, has launched the Clean Oceans campaign to […]
InvestorBrandNetwork Announces Blaze Your Own Trail Podcast featuring Tony DiMatteo, CEO and Co-Founder of Lottery.com
July 16, 2021
LOS ANGELES, July 16, 2021 (GLOBE NEWSWIRE) — – via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that Tony DiMatteo, CEO and co-founder of Lottery.com, a leading technology company that is transforming how, where and when the lottery is played, recently appeared on the Blaze Your Own Trail Podcast, an inspirational […]
InvestorNewsBreaks – Asia Broadband Inc. (AABB) Provides Exchange Development, AABB Wallet Update
July 15, 2021
Asia Broadband (OTC: AABB),a resource company focused on the production, supply and sale of precious and base metals primarily to Asian markets, has reached several significant development milestones as it continues to focus on building a proprietary cryptocurrency exchange. The company has been involved in this project since the March launch of its gold-backed token […]
Energy Fuels (NYSE American: UUUU) (TSX: EFR) Makes First Shipment to Neo Performance Materials Inc. (TSX: NEO) in Emerging US-Based Rare Earth Supply Chain
July 15, 2021
The first container of mixed RE carbonate has been shipped from the United States to Europe. The announcement marks important achievement, not only for UUUU and NEO, but also for U.S. government efforts to restore critical rare earth supply chains. Energy Fuels is the only North American company that currently produces a monazite-derived, enhanced rare […]
InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Upcoming Q3 Investor Day
July 15, 2021
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, will be hosting a third-quarter virtual Investor Day. The company has scheduled this event for July 29, 2021; it will begin at 9 a.m. PDT. Included on the event agenda will […]
Asia Broadband Proprietary Cryptocurrency Exchange Development and AABB Wallet Update
July 15, 2021
LAS VEGAS, July 15, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has continued to achieve numerous development milestones in the initial months of building its proprietary cryptocurrency exchange (the “Exchange”). Subsequent to the March launch of the Company’s AABBG gold-backed token, […]
InvestorNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Announces Upcoming Corporate Update Webinar
July 14, 2021
FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a growth-stage company committed to providing commercially viable and sustainable energy solutions, has scheduled a webinar, during which CEO Ian Clifford will share a brief company overview as well as discuss recent announcements and upcoming milestones. The webinar is slated for July 15, 2021, and will begin at 11 a.m. EST. […]
Friendable Inc.’s (FDBL) Fan Pass 2.0 Arriving with New Features and Upgrades
July 14, 2021
Version 2.0 of the Fan Pass platform will be released on July 24, the first anniversary of Friendable’s flagship offering that provides a virtual stage for artists and fans The new version has been created to enhance the user experience, benefiting both artists and fans who use the platform The latest version of the platform […]
InvestorNewsBreaks – Friendable Inc. (FDBL) Unveils New Corporate Presentation Amid Continued Livestream Entertainment Demand, Announces Fan Pass Milestone
July 13, 2021
Friendable (OTC: FDBL), a mobile technology and marketing company, has launched an updated corporate presentation for existing and potential shareholders to showcase the company’s focus, strategy, messaging, and market opportunity. This move comes as industry research forecasts that the demand for livestreamed entertainment will continue at a steady pace. In addition, the company has announced […]
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Marks Major Milestone for its Rapid Point-Of-Care Diagnostic Business Strategy
July 12, 2021
XPhyto began delivery of approximately 1,000 Covid-ID Lab test kits in Berlin This marks a significant achievement commercially, as well as for the company’s point-of-care diagnostic business strategy The lab tests are designed to offer reliable Covid-19 test results in under 25 minutes XPhyto plans to capitalize on the rapid test market, projected to reach […]
InvestorNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Sees Robust Growth as More Dealers Embrace DRIVRZ(TM)
July 12, 2021
PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a comprehensive e-commerce solution transforming the online experience to sell, trade, lease, and finance vehicles, today announced that its June 2021 financial results demonstrate continuation of robust month-over-month growth, positioning the company for another strong quarter. “We are seeing more dealers embracing the DRIVRZ(TM) platform, resulting in […]
InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Shares Accomplishments that Foreshadow Strong Performance in Weekly Briefing
July 9, 2021
TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) recently shared key achievements and milestones in its TAAT(TM) Weekly Briefing. Among these, the company announced performance that points to a strong fiscal quarter, its building of a solid presence in target metro areas and key retail settings, as well as the promotional exposure that Floyd Mayweather’s team […]
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company
July 8, 2021
Jazz Pharmaceuticals’ acquisition of GW Pharma for $7.2 billion in February 2021 shows the massive potential of the drug development industry from naturally-derived compounds Tryp Therapeutics is following in the footsteps of GW with its innovative drug pipeline and the development of psilocybin-based compounds for the treatment of diseases with high unmet medical needs It […]
InvestorNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L) Announces Move to NYSE American
July 8, 2021
Standard Lithium (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L), an innovative technology and lithium project development company, has received approval to list on the NYSE American LLC. The company expects trading of its outstanding common shares on NYSE American to begin on July 13, 2021, with the opening of the markets; the shares will trade under […]
InvestorNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC), Lottery.com Achieve Significant Milestone Towards Completing Business Combination
July 7, 2021
Trident (NASDAQ: TDAC, TDACU, TDACW) today announced that it has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission (“SEC”) in connection with its proposed business combination with AutoLotto Inc., doing business as Lottery.com. A leading technology company, Lottery.com is transforming how, where and when the lottery is played. “Through […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Milestone in Antiviral Delivery Platform Testing
July 6, 2021
Drug delivery platform developer Lexaria Bioscience has been testing its patented technology in conjunction with antivirals Remdesivir and Ebastine during the past year to determine the potential for enhancing their effectiveness against the COVID-19 virus Early-stage testing has determined Lexaria’s technology — DehydraTECH — did not inhibit Remdesivir and Ebastine in their use against the […]
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Business Update, Progress on Driving Berubicin’s Development
July 1, 2021
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided a business update. Among the highlights, the company reported on its continued progress to drive Berubicin towards commercialization for the treatment of glioblastoma multiforme (“GBM”). “In the […]
Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Status Report on Six Key R&D Programs
July 1, 2021
Lexaria announced significant strides in six of its studies within the 2021 applied R&D program All the studies are based on Lexaria’s DehydraTECH(TM) technology and are designed for multiple market applications, including oral nicotine, NSAIDs, antivirals, and hypertension The 2021 applied R&D program is intended to generate not only confirmatory results and data evidencing but […]
XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Mescaline Program for Psychedelic Therapies is on Track
June 30, 2021
XPhyto Therapeutics Corp (OTCQB: XPHYF) announced its GMP mescaline synthesis program is “on schedule” The program, which started in early 2021, is slated for completion in late Q3 2021 The first initial production batches were completed successfully, marking a significant milestone for the program Mescaline will form a critical component in XPhyto’s psychedelic medicine program […]
InvestorNewsBreaks – Rritual Superfoods Inc. (CSE: RSF) (OTC: RRSFF) (FSE: 0RW) CEO Discusses CVS Launch as Significant Milestone in National Retail Rollout
June 30, 2021
Rritual Superfoods Inc. (CSE: RSF) (OTC: RRSFF) (FSE: 0RW), a functional superfood company that creates natural wellness products supporting a holistic approach to a healthy lifestyle, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community. The audio press […]
NASDAQ-Bound Sustainable Green Team Ltd. (SGTM) Offers Profitable Investment Opportunity Rooted in Sustainability
June 30, 2021
SGTM diverts storm-produced natural waste from landfills and transforms it into organic, environmentally-beneficial products Q1-2021 financial results show 16.7% YOY increase in revenue, 8.6% YOY increase in gross profit SGTM preparing for NASDAQ uplist, recently completed 2-year audit, commenced FORM-10 process to become fully reporting Before they realized massive financial success, the management at Sustainable […]
Rritual Superfoods Featured in Syndicated Broadcast Covering Launch of Product Line in CVS Stores
June 30, 2021
VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) (OTC: RRSFF), a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle, today announces that it has been featured in a broadcast via […]
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Finalizes Supply Agreement with Two German Companies for COVID-19 PCR Test
June 30, 2021
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has inked a master supply agreement with two German diagnostics, testing, and medical logistics companies: Beovita GmbH & Co. KG and Tackleberries GmbH. The two companies run 10 COVID-19 test centers in Berlin. The supply agreement outlines […]
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2021 Financial Results, Corporate Highlights
June 30, 2021
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has reported its financial results for fiscal year ended March 31, 2021; the company also provided a […]
ISW Holdings Inc. (ISWH) Delivers 300 Crypto Miners for Installation
June 29, 2021
ISWH increases efficiency, scale with delivery and installation of new mining rigs Joint venture agreement allows ISW Holdings to expand production capacity Company also exploring potential opportunities through partnership with Bit5ive ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in telehealth, renewable energy and cryptocurrency mining, has announced the delivery […]
HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Marks a Significant Milestone in its European Expansion Plan; Announces New Chief Financial Officer
June 28, 2021
HempFusion Wellness Inc. announces it is offering its new EU-compliant products through Boots Ireland This marks the company’s official entry into the Irish market in what is a significant step in further venturing into the U.K. and Europe as a whole Boots will carry HempFusion’s products in close to 50% of stores in the country […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces Annual Financial Results, Business Highlights and Adelia Milestones
June 28, 2021
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today released financial and business highlights for its financial year ended March 31, 2021. “It has been an incredibly busy and successful year for the Cybin team, expanding both our product development capabilities and our drug development programs,” said Doug Drysdale, CEO […]
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Discusses Its Vision for Addressing Patient Needs
June 25, 2021
In 2021, Tryp Therapeutics plans on expanding its academic collaborations It also plans to initiate Phase 2a clinical studies for its synthetic psilocybin drug product as a way to determine efficacy in patient populations Tryp Therapeutics is constantly working on identifying alternative and better ways to control doses and control the patient experience in their […]
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Host Conference Call to Discuss 2021 FY Results, Provide Business Update
June 25, 2021
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced that it will host a conference call to provide a business update and discuss financial and operating results for its fiscal year […]
Hero Technologies Inc. (HENC) Moves to Strengthen Position in Billion-Dollar Market
June 24, 2021
Sales milestone represents licensees’ ability to successfully support a safe, accessible and effective adult-use industry Billion-dollar mark was reached despite 60-day shutdown of recreational cannabis industry due to COVID-19 Earlier this year, Hero Technologies formed MassCannabis to explore potential opportunities, projects in the state Late last year, the nonmedical cannabis market in Massachusetts hit a […]
Corporate Update: FuelPositive Initiatives Progressing as Planned
June 24, 2021
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — via InvestorWire — FuelPositive Corporation (TSX.V: NHHH) (OTCMKTS: NHHHF) (“FuelPositive” or the “Company”) is issuing the following update to share the status of the company and its various initiatives. “With extensive incoming shareholder inquiries over the last several weeks, we felt it would be helpful to provide a detailed update,” said […]
InvestorNewsBreaks – Clubhouse Media Group Inc. (CMGR) Amasses Over 300 Million Followers in Aggregate Social Media Reach
June 24, 2021
Clubhouse Media Group (OTC: CMGR), an influencer-based marketing and media firm, today announced that it has officially surpassed 300 million total followers in aggregate global social media reach, including followers of its signed influencers and its own Clubhouse Media accounts. As of this week, Clubhouse Media’s total aggregate global social media reach stood at just […]
Clubhouse Media Surpasses 300 Million Followers in Aggregate Social Media Reach
June 24, 2021
LOS ANGELES, CA, June 24, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the “Company”), an influencer-based marketing and media firm, is proud to announce that it has officially surpassed 300 million total followers in aggregate global social media reach, including followers of its signed influencers as well […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate in Access to Giving Virtual Investor Conference
June 23, 2021
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and quality of life for patients who have unmet medical needs, will participate in the Access to Giving investor conference. The conference, scheduled for July 13–15, 2021, is the first of its kind focused on investor education and advocacy. More than […]
InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Recaps Milestones at First Anniversary of Public Trading
June 23, 2021
TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) today provided a summary of several notable accomplishments it has achieved since first listing on the Canadian Securities Exchange (“CSE”) one year ago. The company’s many milestones include the multinational commercialization of TAAT(TM) Original, Smooth and Menthol, the recruitment of experienced management and advisory team members, continued product […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Achieves Key Milestones for Its Acclaim-1 Clinical Trial
June 23, 2021
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that the U.S. Food and Drug Administration (“FDA”) has reviewed and confirmed all comments have been addressed regarding the company’s protocol for the Acclaim-1 clinical trial. The open-label, multi-center Phase 1/2 clinical trial will […]
Golden Triangle Ventures Inc. Announces a Letter to Shareholders from CEO
June 23, 2021
LAS VEGAS, June 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) is pleased to release a mid-year Letter to Shareholders updating current activities and outlining its corporate strategy. Read the full letter: Dear Shareholders, Over the past six months, our Company has acquired several very exciting businesses and […]
InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to be Featured in 12-Part ‘New to the Street’ Interview Series
June 22, 2021
Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, has partnered with “New to the Street,” which spotlights companies on national television. FMW Media today announced that its business TV show has begun filming on the series covering GTVH. According to the update, Jane King, the […]
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Emaginos Inc. President Allan Jones
June 22, 2021
LOS ANGELES, June 22, 2021 (GLOBE NEWSWIRE) — (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Stock2Me Podcast features a […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gains Inclusion on Russell 2000 Index as Brain Cancer Trial Enrollment Advances
June 21, 2021
Brain cancer drug developer CNS Pharmaceuticals is actively enrolling patients for a potentially pivotal Phase 2 trial of the company’s lead drug candidate, Berubicin, a promising candidate for treating a devastating condition CNS’s focus has been on developing a means of combating glioblastoma, a fatal, generally incurable class of brain cancers that are aggressive and […]